Vapotherm Closes $24 Million Series B Financing Round

EXETER, N.H., April 3, 2014 /PRNewswire/ — On March 21, 2014, Vapotherm closed a $24MM financing round. Gilde Healthcare Partners, L.P., led the financing round, which also included new investor Adage Capital Management, L.P. and existing investors 3×5 Special Opportunity Fund, Morgenthaler Ventures, Kaiser Permanente, Integral Capital Partners, QuestMark Partners and Cross Creek Capital.

“We are excited by the Vapotherm opportunity and delighted to join the investor group,” said Geoff Pardo, General Partner of Gilde Healthcare Partners, and new member of the Board of Directors. “Vapotherm’s proprietary technology has proven to generate superior patient outcomes and lower the cost of care for providers. We look forward to the company growing and improving healthcare for patients world wide.”

“We are delighted to have Gilde and Adage join our existing investors. They both have strong track records in supporting growing medical device companies and we appreciate their confidence in our team and our products,” said Joe Army, President & CEO. 

Vapotherm, Inc. is a privately held developer and manufacturer of advanced respiratory care technology based in Exeter, New Hampshire. The company develops innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 1,000,000 patients have been treated with Vapotherm High Flow Therapy. For more information, visit

Contact: John Landry, CFO (603) 658-0011

2017-07-24T23:40:35-04:00Apr 3|Vapotherm Company News|
Go to Top